{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:34:56Z","timestamp":1752230096963},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,19]]},"DOI":"10.7759\/cureus.37818","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T12:07:40Z","timestamp":1681906060000},"source":"Crossref","is-referenced-by-count":1,"title":["Losartan-Induced Angioedema: A Case Report"],"prefix":"10.7759","author":[{"given":"Henry","family":"Mann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagar","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sindhu","family":"Pokhriyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Kusayev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alix","family":"Dufresne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/jch.13097","article-title":"Angiotensin-converting enzyme inhibitor-induced angioedema: a review of the literature","volume":"19","author":"Brown T","year":"2017","unstructured":"Brown T, Gonzalez J, Monteleone C. Angiotensin-converting enzyme inhibitor-induced angioedema: a review of the literature. J Clin Hypertens (Greenwich). 2017, 19:1377-82. 10.1111\/jch.13097","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2005.05141.x","article-title":"Angiotensin receptor blockers: new considerations in their mechanism of action","volume":"8","author":"Sica DA","year":"2006","unstructured":"Sica DA. Angiotensin receptor blockers: new considerations in their mechanism of action. J Clin Hypertens (Greenwich). 2006, 8:381-5. 10.1111\/j.1524-6175.2005.05141.x","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/all.12380","article-title":"Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group","volume":"69","author":"Cicardi M","year":"2014","unstructured":"Cicardi M, Aberer W, Banerji A, et al.. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014, 69:602-16. 10.1111\/all.12380","journal-title":"Allergy"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000153269.07762.3B","article-title":"Losartan increases bradykinin levels in hypertensive humans","volume":"111","author":"Campbell DJ","year":"2005","unstructured":"Campbell DJ, Krum H, Esler MD. Losartan increases bradykinin levels in hypertensive humans. Circulation. 2005, 111:315-20. 10.1161\/01.CIR.0000153269.07762.3B","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00877.x","article-title":"The angiotensin type II receptor tonically inhibits angiotensin- converting enzyme in AT2 null mutant mice","volume":"57","author":"Hunley TE","year":"2000","unstructured":"Hunley TE, Tamura M, Stoneking BJ, Nishimura H, Ichiki T, Inagami T, Kon V. The angiotensin type II receptor tonically inhibits angiotensin- converting enzyme in AT2 null mutant mice. Kidney Int. 2000, 57:570-7. 10.1046\/j.1523-1755.2000.00877.x","journal-title":"Kidney Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1C520","article-title":"Valsartan-induced angioedema","volume":"37","author":"Irons BK","year":"2003","unstructured":"Irons BK, Kumar A. Valsartan-induced angioedema. Ann Pharmacother. 2003, 37:1024-7. 10.1345\/aph.1C520","journal-title":"Ann Pharmacother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1592\/phco.22.13.1176.33516","article-title":"Angioedema associated with candesartan","volume":"22","author":"Lo KS","year":"2002","unstructured":"Lo KS. Angioedema associated with candesartan. Pharmacotherapy. 2002, 22:1176-9. 10.1592\/phco.22.13.1176.33516","journal-title":"Pharmacotherapy"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H566","article-title":"Olmesartan medoxomil-induced angioedema","volume":"41","author":"Nykamp D","year":"2007","unstructured":"Nykamp D, Winter EE. Olmesartan medoxomil-induced angioedema. Ann Pharmacother. 2007, 41:518-20. 10.1345\/aph.1H566","journal-title":"Ann Pharmacother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2010.11.014","article-title":"Angiotensin II receptor blocker-induced angioedema in the oral floor and epiglottis","volume":"32","author":"Shino M","year":"2011","unstructured":"Shino M, Takahashi K, Murata T, Iida H, Yasuoka Y, Furuya N. Angiotensin II receptor blocker-induced angioedema in the oral floor and epiglottis. Am J Otolaryngol. 2011, 32:624-6. 10.1016\/j.amjoto.2010.11.014","journal-title":"Am J Otolaryngol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.anl.2009.07.006","article-title":"Angioedema: 6 years experience with fourteen cases","volume":"37","author":"Taki M","year":"2010","unstructured":"Taki M, Watanabe H, Hasegawa T, Bamba H, Shimada T, Hisa Y. Angioedema: 6 years experience with fourteen cases. Auris Nasus Larynx. 2010, 37:199-204. 10.1016\/j.anl.2009.07.006","journal-title":"Auris Nasus Larynx"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.03.017","article-title":"Cardiovascular and diabetic medications that cause bradykinin-mediated angioedema","volume":"5","author":"Hudey SN","year":"2017","unstructured":"Hudey SN, Westermann-Clark E, Lockey RF. Cardiovascular and diabetic medications that cause bradykinin-mediated angioedema. J Allergy Clin Immunol Pract. 2017, 5:610-5. 10.1016\/j.jaip.2017.03.017","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/146848-losartan-induced-angioedema-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:59Z","timestamp":1707508799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/146848-losartan-induced-angioedema-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.37818","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,19]]}}}